Moffitt logo

Clinical Trials Search

Clinical Trial 20601

Cancer Type: Healthy Subjects
Study Type: Screening
NCT#: NCT04980157

Phase: N/A
Principal Investigator: Christy, Shannon

Call 813-745-6100
or 1-800-679-0775 Learn More

Study Title

CARES-HCV: Promoting Concurrent Hepatitis C Virus Screening and Colorectal Cancer Screening Uptake Among Diverse Baby Boomers


The purpose of the study is to examine the efficacy of educational materials to promote hepatitis C virus (HCV) screening and colorectal cancer (CRC) screening uptake among adults born between 1945-1965.


Specific Aim #1. Examine intervention effects on HCV and CRC knowledge, health beliefs, and screening intentions 1 week post-intervention among 80 diverse Baby Boomers. Specific Aim #2. Evaluate post-intervention uptake rates for CRC screening, HCV screening, and both behaviors concurrently at 6 months follow-up and examine predictors of uptake. Specific Aim #3. Explore the resource utilization and costs of the CARES-HCV intervention to promote HCV and CRC screening behaviors.




Inclusion Criteria

Inclusion Criteria:

  • Born between 1945 and 1965
  • No personal history of colorectal cancer (CRC) or current presumptive colorectal cancer symptoms (e.g., unresolved rectal bleeding or abdominal pain/bloating)
  • No personal history of hepatitis C virus (HCV) or liver cancer
  • Able to read, write, speak, and understand English or Spanish
  • Not currently enrolled in another CRC screening or a HCV screening study
  • At average risk for CRC (that is, no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC)
  • Not currently up-to date with CRC screenings
  • Not having previously completed HCV screening
  • Able and willing to complete a phone interview
  • Able to provide informed consent

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.